Neurochemists study the chemical foundations of brain activity, focusing on the roles of neurotransmitters, receptors, and signaling pathways that influence neural function. Their research helps explain how imbalances in brain chemistry contribute to disorders like depression, schizophrenia, and neurodegenerative diseases such as Parkinson's. Neurochemists investigate the synthesis, release, and recycling of neurotransmitters like dopamine, serotonin, and glutamate, which are key targets for many neurological and psychiatric treatments. Using advanced techniques such as chromatography, mass spectrometry, and molecular assays, they analyze the chemical composition of brain tissue and cerebrospinal fluid, providing critical insights into brain function and dysfunction.
Additionally, neurochemists explore the impact of neuropeptides, oxidative stress, and lipid signaling in processes such as neuroinflammation and neurodegeneration. By collaborating with neuropharmacologists and neurobiologists, they play a pivotal role in designing more effective, targeted therapies with fewer side effects. Their work also includes understanding how lifestyle factors such as diet, environmental exposure, and aging influence brain chemistry, contributing to the field of precision medicine. With this approach, neurochemists are advancing personalized treatment strategies that track and treat neurological conditions with greater accuracy.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States